sr141716 has been researched along with Morphine Abuse in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, CP; Lang, ST; Leri, F; Manwell, LA; Parker, LA; Satvat, E | 1 |
| Aguilar, MA; Manzanedo, C; Miñarro, J; Navarro, M; Rodríguez-Arias, M | 1 |
| Chowen, J; de Fonseca, FR; del Arco, I; Koob, GF; Martin, Y; Navarro, M; Roberts, AJ; Rocío A Carrera, M; Villanúa, MA | 1 |
| Fuzio, D; Massi, P; Parolaro, D; Rubino, T; Viganò, D | 1 |
| Carrera, MR; Chowen, JA; Cossu, G; del Arco, I; Fattore, L; Fratta, W; Gomez, R; Koob, GF; Maldonado, R; Navarro, M; Rodriguez de Fonseca, F; Valverde, O; Villanua, MA | 1 |
| Lichtman, AH; Loh, HH; Martin, BR; Sheikh, SM | 1 |
6 other study(ies) available for sr141716 and Morphine Abuse
| Article | Year |
|---|---|
FAAH inhibitor, URB-597, promotes extinction and CB(1) antagonist, SR141716, inhibits extinction of conditioned aversion produced by naloxone-precipitated morphine withdrawal, but not extinction of conditioned preference produced by morphine in rats.
Topics: Amidohydrolases; Animals; Benzamides; Cannabinoid Receptor Modulators; Carbamates; Choice Behavior; Conditioning, Psychological; Dietary Sucrose; Extinction, Psychological; Female; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Piperidines; Pyrazoles; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Reinforcement Schedule; Rimonabant; Species Specificity; Substance Withdrawal Syndrome | 2009 |
Cannabinoid agonist-induced sensitisation to morphine place preference in mice.
Topics: Animals; Behavior, Animal; Benzoxazines; Brain; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cannabinoid Receptor Modulators; Cannabinoids; Dose-Response Relationship, Drug; Drug Interactions; Male; Mice; Morphine; Morphine Dependence; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Receptors, Cannabinoid; Reward; Rimonabant; Spatial Behavior | 2004 |
CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats.
Topics: Animals; Brain Chemistry; Gene Expression; In Situ Hybridization; Male; Morphine Dependence; Naloxone; Narcotic Antagonists; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Receptors, Opioid, mu; Rimonabant; RNA, Messenger; Substance Withdrawal Syndrome | 1998 |
Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndrome.
Topics: Analysis of Variance; Animals; Cannabinoids; Dogs; Drug Interactions; Drug Tolerance; Male; Morphine; Morphine Dependence; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Substance Withdrawal Syndrome | 2000 |
Functional interaction between opioid and cannabinoid receptors in drug self-administration.
Topics: Animals; Avoidance Learning; Cannabinoids; Caudate Nucleus; Conditioning, Operant; Disease Models, Animal; Heroin; Heroin Dependence; Male; Mice; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Nucleus Accumbens; Piperidines; Putamen; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Receptors, Opioid; Rimonabant; RNA, Messenger; Self Administration; Septum of Brain | 2001 |
Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.
Topics: Animals; Behavior, Animal; Cannabinoids; Diarrhea; Dronabinol; Drug Implants; Hallucinogens; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Inbred ICR; Mice, Knockout; Morphine; Morphine Dependence; Narcotics; Opioid Peptides; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Receptors, Opioid, mu; Rimonabant; Substance Withdrawal Syndrome | 2001 |